Table 2.
Case Report | Vaccine | Age, Sex | Time to Symptom Onset | Peak CK Level | Acute Kidney Failure | Outcome | Note |
---|---|---|---|---|---|---|---|
Tan et al., 2021 | ChAdOx1 nCoV-19 (AstraZeneca) |
27, m | 5 h | 250,000 U/L | no | recovered | known CPT2 deficiency |
Mack et al., 2021 | mRNA-1273 (Moderna) |
80, m | 2 days | 6546 U/L | no | recovered | - |
Nassar et al., 2021 | BNT161b2 mRNA (Pfizer/BioNTech) | 21, m | 1 day | >22,000 U/L | no | recovered | - |